, Volume 58, Issue 2, pp 320–331 | Cite as

Incidence and all-cause mortality for hip fracture in comparison to stroke, and myocardial infarction: a fifteen years population-based longitudinal study

  • Vincenzo CarnevaleEmail author
  • Andrea Fontana
  • Alfredo Scillitani
  • Roberto Sinisi
  • Elisabetta Romagnoli
  • Massimiliano Copetti
Original Article



This population-based study investigated the incidence, in-hospital and long-term all-cause mortality, for hip fracture (HipFx), stroke (STR), and myocardial infarction (MI) in residents hospitalized between 2000 and 2014.


Data about hospitalization were drawn from the administrative discharge database, whereas information about residents and all-cause mortality from the municipality of our town. Patients were followed-up from the first hospital admission until death or study end. For each cause, crude and age-adjusted all-cause mortality of men and women were compared by Mann–Whitney’s test and Poisson models. Separate age-sex adjusted Cox models were estimated and the corresponding adjusted survival curves were drawn.


Among 1292 hospitalizations (of 1109 patients), 434 were for HipFx, 526 for STR, 332 for MI (183 with and 149 without coronary revascularization –MIwCR and MIwoCR, respectively). The incidence of HipFx and STR did not vary over time, MI slightly increasing in men. Age-adjusted in-hospital mortality for HipFx was lower than for STR and MIwoCR in the whole sample and in women (p < 0.001), but not in men. After discharge, men with HipFx had shorter survival and higher crude and age-adjusted mortality rate than women. The estimated HRs(95%CI) in respect to patients with MIwCR (having the lowest mortality) were: 6.11(3.12–11.97), p < 0.001 for HipFx; 5.78(2.93–11.32), p < 0.001 for STR; 2.68(1.27–5.66), p = 0.010 for MIwoCR in the whole sample [HR: 16.58(6.70–40.98) p < 0.001 for HipFx; 7.35(3.01–17.93) p < 0.001 for STR, in men].


HipFx markedly impacts hospital care, and causes high in-hospital and long-term all-cause mortality, comparable to the two commonest non-tumor causes of death.


Hip fracture Stroke Myocardial infarction Hospital admission Mortality 


Compliance with ethical standards

Conflict of interest

The authors declare they have no competing interests.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Supplementary material

12020_2017_1423_MOESM1_ESM.doc (326 kb)
Supplementary Tables
12020_2017_1423_MOESM2_ESM.doc (32 kb)
Supplementary Information


  1. 1.
    M.J. Prince, F. Wu, Y. Guo et al. The burden of disease in older people and implications for the health policy and practice. Lancet 385, 549–562 (2015)CrossRefPubMedGoogle Scholar
  2. 2.
    P. Piscitelli, M. Feola, C. Rao et al. Ten years of hip fractures in Italy: for the first time a decreasing trend in elderly women. World J. Orthop. 5, 386–391 (2014)CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    S.R. Cummings, L.J. Melton III, Epidemiology and outcomes of osteoporotic fractures. Lancet 359, 1761–1767 (2002)CrossRefPubMedGoogle Scholar
  4. 4.
    C.A. Brauer, M. Coca-Perraillon, D.M. Cutler, A.B. Rosen, Incidence and mortality of hip fractures in the United States. JAMA 302, 1573–1579 (2009)CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    C. Cooper, Z.A. Cole, C.R. Holroyd et al. Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos. Int. 22, 1277–1288 (2011)CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    P. Piscitelli, F. Gimigliano, S. Gatto et al. Hip fractures in Italy: 2000-2005 extension study. Osteoporos. Int. 21, 1323–1330 (2010)CrossRefPubMedGoogle Scholar
  7. 7.
    F. Nilson, S. Moniruzzaman, J. Gustavsson, R. Andersson, Trends in hip fracture incidence rates among the elderly in Sweden 1987-2009. J. Public Health 35, 125–131 (2012)CrossRefGoogle Scholar
  8. 8.
    N. Williams, B.M. Hardy, S. Tarrant, et al. Changes in hip fracture incidence, mortality and length of stay over the last decade in an Australian major trauma centre. Arch. Osteoporos. (2013) 150Google Scholar
  9. 9.
    S. Mundi, B. Pindiprolu, N. Simunovic, M. Bhandari, Similar mortality rates in hip fracture patients over the past 31 years. Acta. Orthop. 85, 54–59 (2014)CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    S. Morin, L.M. Lix, M. Azimaee, C. Metge, P. Caetano, W.D. Leslie, Mortality rates after incident non traumatic fractures in older men and women. Osteoporos. Int. 22, 2439–2448 (2001)CrossRefGoogle Scholar
  11. 11.
    L.J. Melton III, S.J. Achenbach, E.J. Atkinson, T.M. Therneau, S. Amin, Long-term mortality following fractures at different skeletal sites: a population-based cohort study. Osteoporos. Int. 24, 1689–1696 (2013)CrossRefPubMedGoogle Scholar
  12. 12.
    B. Abrahamsen, T. van Staa, R. Ariely, M. Olson, C. Cooper, Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos. Int. 20, 1633–1650 (2009)CrossRefPubMedGoogle Scholar
  13. 13.
    J.R. Center, T.V. Nguyen, D. Schneider, P.N. Sambrook, J.A. Eisman, Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353, 878–882 (1999)CrossRefPubMedGoogle Scholar
  14. 14.
    G. Ioannidis, A. Papaioannou, W.M. Hopman et al. Relation between fractures and mortality: Results from the Canadian multicentre osteoporosis study. CMAJ 181, 265–271 (2009)CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    L. Forsén, A.J. Søgaard, H.E. Meyer, T.H. Edna, B. Kopjar, Survival after hip fracture: short- and long-term excess mortality according to age and gender. Osteoporos. Int. 10, 73–78 (1999)CrossRefPubMedGoogle Scholar
  16. 16.
    M. Tsuboi, Y. Hasegawa, S. Suzuki, H. Wingstrand, K.G. Thorngren, Mortality ad mobility after hip fracture in Japan. J. Bone Joint Surg. 89, 461–466 (2007). BCrossRefGoogle Scholar
  17. 17.
    P. Vestergaard, L. Rejnmark, L. Mosekilde, Increased mortality in patients with a hip fracture-effect of premorbid conditions and post-fracture complications. Osteoporos. Int. 18, 1583–1593 (2007)CrossRefPubMedGoogle Scholar
  18. 18.
    A.Y.J. Lee, J. Tan, S.M.C. Fook-Chong, N.N. Lo, T.S. Howe, Five-year outcome of individuals with hip fracture admitted to a Singapore hospital: quality of life and survival rates after treatment. J. Am. Geriatr. 60, 994–996 (2012)CrossRefGoogle Scholar
  19. 19.
    P. Haentjens, J. Magaziner, C.S. Colón-Emeric et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann. Intern. Med. 152, 380–390 (2010)CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    V.L. Feigin, M.H. Farouzanfar, R. Krishnamurthi et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 383, 245–255 (2014)CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    R. Carandang, S. Seshadri, A. Beiser et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 296, 2939–2946 (2006)CrossRefPubMedGoogle Scholar
  22. 22.
    M.C. Fang, M.C. Perraillon, K. Ghosh, D.M. Cutler, A.B. Rosen, Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008. Am. J. Med. 127, 608–615 (2014)CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    E.S. Ford, U.A. Ajani, J.B. Croft et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N. Engl. J. Med. 356, 2388–2398 (2007)CrossRefPubMedGoogle Scholar
  24. 24.
    S. Setoguchi, R.J. Glynn, J. Avorn, M.A. Mittleman, R. Levin, W.C. Winkelmeyer, Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge. J. Am. Coll. Cardiol. 51, 1247–1254 (2008)CrossRefPubMedGoogle Scholar
  25. 25.
    S.T. Nauta, J. Deckers, K.M. Akkerhuis, R.T. van Domburg, Short- and long-term mortality after myocardial infarction in patients with and without diabetes. Diabetes Care 35, 2043–2047 (2012)CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    A. Svedbom, E. Hernlund, M. Ivergård, et al. Epidemiology and economic burden of osteoporosis in Italy. Arch. Osteoporos. (2013)
  27. 27.
    H.M. Krumholz, S.-L.T. Normand, Y. Wang, Trends in hospitalizations and outcomes for acute cardiovascular disease and stroke, 1999-2011. Circulation 130, 966–975 (2014)CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    E.S. Spatz, A.L. Beckman, Y. Wang, H.M. Krumholz, Geographic variation in trends and disparities in acute myocardial infarction hospitalization and mortality by income levels, 1999-2013. JAMA Cardiol. 1, 255–265 (2016)CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    I.R. Dégano, V. Salomaa, G. Veronesi et al. Twenty-five year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations. Heart 101, 1413–1421 (2015)CrossRefPubMedGoogle Scholar
  30. 30.
    J.A. Kanis, A. Oden, O. Johnell, C. De Laet, B. Jonsson, A.K. Oglesby, The components of excess mortality after hip fracture. Bone 32, 468–473 (2003)CrossRefPubMedGoogle Scholar
  31. 31.
    M. von Friesendorff, F.E. McGuigan, A. Wizert et al. Hip fractures, mortality risk, and cause of death over two decades. Osteoporos. Int. 27, 2945–2953 (2016)CrossRefGoogle Scholar
  32. 32.
    H.X. Jiang, S.R. Majumdar, D.A. Dick et al. Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures. J. Bone. Miner. Res. 20, 494–500 (2005)CrossRefPubMedGoogle Scholar
  33. 33.
    V. Carnevale, L. Nieddu, E. Romagnoli et al. Osteoporosis intervention in ambulatory patients with previous hip fracture: a multicentric nationwide Italian Survey. Osteoporos. Int. 17, 478–483 (2006)CrossRefPubMedGoogle Scholar
  34. 34.
    L. Luan, R. Li, Z. Wang et al. Stroke increases the risk of hip fracture: a systematic review and meta-analysis. Osteoporos. Int. 27, 3149–3154 (2016)CrossRefPubMedGoogle Scholar
  35. 35.
    J.H. Kang, S.-D. Chung, S. Xirasagar, F.-S. Jaw, H.-C. Lin, Increased risk of stroke in the year after a hip fracture. A population-based follow-up study. Stroke 42, 336–341 (2011)CrossRefPubMedGoogle Scholar
  36. 36.
    C.H. Tsai, C.-L. Liu, H.-C. Hsu, W.-S. Chung, Increased risk of stroke among hip fracture patients: a nationwide cohort study. Osteoporos. Int. 26, 645–652 (2015)CrossRefPubMedGoogle Scholar
  37. 37.
    C.-H. Chiang, C.-J. Liu, P.-J. Chen et al. Hip fracture and risk of acute myocardial infarction: a nationwide study. J. Bone Miner. Res. 28, 404–411 (2013)CrossRefPubMedGoogle Scholar
  38. 38.
    L’evoluzione della mortalità per causa: le prime 25 cause di morte. Accessed 09 May 2017Google Scholar
  39. 39.
    I.D. Cameron, J.S. Chen, L.M. March et al. Hip fracture causes excess mortality owing to cardiovascular and infectious disease in institutionalized older people: a prospective 5-year study. J. Bone Miner. Res. 25, 866–872 (2010)PubMedGoogle Scholar
  40. 40.
    J.P. Holm, L. Hyldstrup, J.B. Jensen, Time trends in osteoporosis risk factor profile: a comparative analysis of risk factors, comorbidities, and medications over twelve years. Endocrine 54, 241–255 (2016)CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Vincenzo Carnevale
    • 1
    Email author
  • Andrea Fontana
    • 2
  • Alfredo Scillitani
    • 3
  • Roberto Sinisi
    • 4
  • Elisabetta Romagnoli
    • 5
  • Massimiliano Copetti
    • 2
  1. 1.Units of Internal Medicine, “Casa Sollievo della Sofferenza” Hospital, IRCCSSan Giovanni RotondoItaly
  2. 2.Units of Biostatistics, “Casa Sollievo della Sofferenza” Hospital, IRCCSSan Giovanni RotondoItaly
  3. 3.Units of Endocrinology, “Casa Sollievo della Sofferenza” Hospital, IRCCSSan Giovanni RotondoItaly
  4. 4.Health Statistics, “Casa Sollievo della Sofferenza” Hospital, IRCCSSan Giovanni RotondoItaly
  5. 5.Department of Experimental Medicine“Sapienza” UniversityRomeItaly

Personalised recommendations